Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 CHF
−51.40 M CHF
3.67 B CHF
84.27 M
About GALDERMA GROUP N
Sector
CEO
Flemming Ørnskov
Headquarters
Zug
Website
Founded
1981
ISIN
CH1335392721
FIGI
BBG01LYFLBQ5
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GALD is 100.64 CHF — it has increased by 0.08% in the past 24 hours. Watch GALDERMA GROUP N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange GALDERMA GROUP N stocks are traded under the ticker GALD.
GALD stock has risen by 4.08% compared to the previous week, the month change is a 11.64% rise, over the last year GALDERMA GROUP N has showed a 64.98% increase.
We've gathered analysts' opinions on GALDERMA GROUP N future price: according to them, GALD price has a max estimate of 106.97 CHF and a min estimate of 83.58 CHF. Watch GALD chart and read a more detailed GALDERMA GROUP N stock forecast: see what analysts think of GALDERMA GROUP N and suggest that you do with its stocks.
GALD reached its all-time high on Dec 27, 2024 with the price of 100.60 CHF, and its all-time low was 60.00 CHF and was reached on Mar 22, 2024. View more price dynamics on GALD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GALD stock is 1.08% volatile and has beta coefficient of 0.10. Track GALDERMA GROUP N stock price on the chart and check out the list of the most volatile stocks — is GALDERMA GROUP N there?
Today GALDERMA GROUP N has the market capitalization of 23.85 B, it has increased by 3.59% over the last week.
Yes, you can track GALDERMA GROUP N financials in yearly and quarterly reports right on TradingView.
GALDERMA GROUP N is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
GALD earnings for the last half-year are 0.79 CHF per share, whereas the estimation was 0.90 CHF, resulting in a −12.00% surprise. The estimated earnings for the next half-year are 0.81 CHF per share. See more details about GALDERMA GROUP N earnings.
GALDERMA GROUP N revenue for the last half-year amounts to 1.98 B CHF, despite the estimated figure of 1.98 B CHF. In the next half-year revenue is expected to reach 2.02 B CHF.
GALD net income for the last half-year is 41.81 M CHF, while the previous report showed −54.18 M CHF of net income which accounts for 177.17% change. Track more GALDERMA GROUP N financial stats to get the full picture.
No, GALD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 6.54 K employees. See our rating of the largest employees — is GALDERMA GROUP N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GALDERMA GROUP N EBITDA is 780.58 M CHF, and current EBITDA margin is 20.89%. See more stats in GALDERMA GROUP N financial statements.
Like other stocks, GALD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GALDERMA GROUP N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GALDERMA GROUP N technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GALDERMA GROUP N stock shows the strong buy signal. See more of GALDERMA GROUP N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.